US Stock MarketDetailed Quotes
LXRX Lexicon Pharmaceuticals
- 1.610
- -0.060-3.59%
Close May 23 16:00 ET
- 1.630
- +0.020+1.23%
Post 17:35 ET
582.00MMarket Cap-1939P/E (TTM)
1.680High1.585Low2.28MVolume1.680Open1.670Pre Close3.69MTurnover1.25%Turnover RatioLossP/E (Static)361.49MShares3.73052wk High2.02P/B293.22MFloat Cap0.92052wk Low--Dividend TTM182.12MShs Float344.750Historical High--Div YieldTTM5.69%Amplitude0.920Historical Low1.617Avg Price1Lot Size
Lexicon Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -74.39%-55.13M | -82.21%-161.9M | -134.35%-50.55M | -114.10%-41.62M | -56.08%-38.12M | -34.98%-31.61M | -2.11%-88.85M | 5.52%-21.57M | -13.35%-19.44M | -11.62%-24.42M |
| Net income from continuing operations | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M | -1.15%-23.39M | -36.09%-24.59M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | -93.88%3K | ---- | ---- | ---- |
| Depreciation and amortization | 28.57%144K | 29.74%554K | 42.72%147K | 39.81%151K | 34.58%144K | 2.75%112K | 46.23%427K | -8.04%103K | 6.93%108K | 154.76%107K |
| Other non cash items | 9.81%291K | -414.57%-2.33M | -63.48%126K | -1,480.18%-3M | 77.27%273K | 960.00%265K | 1,272.22%741K | 4,212.50%345K | 1,176.47%217K | 926.67%154K |
| Change In working capital | -230.45%-11.47M | 561.44%2.66M | -182.16%-4.28M | 705.33%7.85M | 187.26%2.56M | -21.75%-3.47M | 103.93%402K | 1,248.70%5.21M | -68.97%975K | 56.01%-2.93M |
| -Change in receivables | -120.51%-516K | -6,914.29%-982K | -5,866.67%-692K | 6,216.67%367K | -14,200.00%-423K | -917.39%-234K | -103.67%-14K | 33.33%12K | -104.41%-6K | 105.17%3K |
| -Change in inventory | ---133K | ---381K | ---45K | ---164K | ---172K | --0 | --0 | --0 | --0 | ---- |
| -Change in prepaid assets | -116.72%-1.88M | -817.41%-2.9M | -725.97%-964K | 551.91%1.71M | -176.22%-2.78M | -417.58%-867K | -110.95%-316K | -82.89%154K | -82.92%262K | -56.06%-1.01M |
| -Change in payables and accrued expense | -228.81%-9.11M | 8,392.11%6.45M | -156.31%-2.65M | 654.69%6.11M | 369.52%5.77M | 16.26%-2.77M | 100.54%76K | 750.07%4.71M | -36.42%810K | 65.99%-2.14M |
| -Change in other current assets | -58.50%166K | -28.81%467K | -76.15%78K | -89.01%-172K | -24.41%161K | 93.24%400K | -0.76%656K | 61.88%327K | -145.96%-91K | -36.42%213K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -74.39%-55.13M | -82.21%-161.9M | -134.35%-50.55M | -114.10%-41.62M | -56.08%-38.12M | -34.98%-31.61M | -2.11%-88.85M | 5.52%-21.57M | -13.35%-19.44M | -11.62%-24.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,011.47%-110.22M | 29.73%-49.94M | 114.69%51.9M | 49.06%-39.33M | -446.66%-74.61M | 374.34%12.09M | -3,468.63%-71.08M | 296.56%24.17M | -19,199.00%-77.2M | -196.53%-13.65M |
| Net PPE purchase and sale | --0 | 64.56%-470K | --0 | -1,975.00%-83K | ---139K | -226.32%-248K | -8.60%-1.33M | -5,317.39%-1.25M | 98.12%-4K | --0 |
| Net investment purchase and sale | -993.15%-110.22M | 29.07%-49.47M | 104.16%51.9M | 49.16%-39.24M | -445.64%-74.47M | 384.88%12.34M | -2,194.03%-69.75M | 315.43%25.42M | -41,179.14%-77.19M | -190.47%-13.65M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,011.47%-110.22M | 29.73%-49.94M | 114.69%51.9M | 49.06%-39.33M | -446.66%-74.61M | 374.34%12.09M | -3,468.63%-71.08M | 296.56%24.17M | -19,199.00%-77.2M | -196.53%-13.65M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 29,151.33%239.38M | 32.17%187.96M | -100.00%-1K | -100.22%-210K | 189M | -103.54%-824K | 526.22%142.21M | 320.00%24.91M | 375.30%94.02M | 0 |
| Net issuance payments of debt | ---- | 2.24%49.96M | -100.00%-1K | 100.40%1K | ---- | ---- | 517.68%48.87M | 313.41%24.97M | ---249K | --0 |
| Net common stock issuance | -99.27%-1.64M | 47.84%138M | --0 | -100.22%-211K | --139.03M | 4.63%-824K | 171.27%93.34M | -116.62%-63K | 376.56%94.27M | --0 |
| Net preferred stock issuance | --241.43M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---400K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 29,151.33%239.38M | 32.17%187.96M | -100.00%-1K | -100.22%-210K | --189M | -103.54%-824K | 526.22%142.21M | 320.00%24.91M | 375.30%94.02M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -51.53%22.47M | -27.66%46.35M | 12.12%21.12M | 376.79%102.27M | -56.32%26M | -27.66%46.35M | -49.26%64.07M | -79.55%18.83M | -76.14%21.45M | -39.05%59.52M |
| Current changes in cash | 463.89%74.03M | -34.76%-23.88M | -95.10%1.35M | -3,002.26%-81.16M | 300.34%76.27M | -347.61%-20.34M | 71.51%-17.72M | 198.07%27.51M | -217.26%-2.62M | -390.28%-38.07M |
| End cash Position | 271.12%96.49M | -51.53%22.47M | -51.53%22.47M | 12.12%21.12M | 376.79%102.27M | -56.32%26M | -27.66%46.35M | -27.66%46.35M | -79.55%18.83M | -76.14%21.45M |
| Free cash flow | -73.03%-55.13M | -80.05%-162.37M | -121.56%-50.55M | -114.48%-41.7M | -56.65%-38.26M | -35.60%-31.86M | -2.20%-90.18M | 0.16%-22.82M | -11.98%-19.44M | -6.99%-24.42M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg